Sign in

MapLight Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22
Total revenue 0.00
Cost of revenue 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00
Total operating expenses + 0.17 0.08 0.06 0.03
Operating income -0.17 -0.08 -0.06 -0.03
Non-operating income (net) 0.01 0.01 0.00 0.00
Income before tax -0.16 -0.08 -0.06 -0.03
Net income -0.16 -0.08 -0.06 -0.03
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Mar-23
Total revenue 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.06 0.08 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.01
Operating income -0.06 -0.08 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.06 -0.08 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01
Net income -0.06 -0.08 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22
Total cash and short-term investments + 0.31 0.11 0.08 0.03
Other current assets 0.02 0.01 0.00 0.00
Total current assets 0.32 0.11 0.08 0.03
Total non-current assets + 0.15 0.02 0.01 0.01
Total assets 0.48 0.14 0.09 0.04
Total current liabilities + 0.02 0.02 0.01 0.01
Total non-current liabilities + 0.00 0.01 0.01 0.01
Total liabilities 0.02 0.02 0.02 0.02
Total stockholders' equity + 0.46 0.12 0.07 0.02
Common shares outstanding 44 41 41 41
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Mar-23
Total cash and short-term investments + 0.31 0.31 0.23 0.06 0.09 0.11 0.00 0.00 0.18 0.00
Other current assets 0.02 0.02 0.02 0.01 0.01 0.01 0.00 -0.03
Total current assets 0.33 0.32 0.25 0.07 0.10 0.11 0.18
Total non-current assets + 0.09 0.15 0.01 0.01 0.01 0.02 0.01
Total assets 0.42 0.48 0.26 0.08 0.11 0.14 0.19
Total current liabilities + 0.01 0.02 0.02 0.01 0.01 0.02 0.01
Total non-current liabilities + 0.00 0.00 0.01 0.01 0.01 0.31 0.01 -0.02
Total liabilities 0.02 0.02 0.02 0.02 0.02 0.33 0.02 -0.02
Total stockholders' equity + 0.40 0.46 0.23 0.06 0.09 0.12 0.17 0.02
Common shares outstanding 45 44 41 41 41 41 41 41 41 41
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22
Operating cash flow + -0.14 -0.08 -0.05 -0.03
Cash flow from investing + -0.32 -0.08 0.00 0.00
Cash flow from financing + 0.47 0.12 0.10 0.03
Change in cash 0.01 -0.04 0.05 0.01
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Mar-23
Operating cash flow + -0.05 -0.05 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.01
Cash flow from investing + 0.07 -0.24 -0.14 0.02 0.04 0.03 0.01 -0.12 0.00 0.00
Cash flow from financing + -0.01 0.27 0.20 0.00 0.00 0.00 0.00 0.00 0.12 0.00
Change in cash 0.01 -0.02 0.03 -0.02 0.01 0.01 -0.01 -0.14 0.10 -0.01
5 days ago

MapLight Therapeutics, Inc. (MPLT) - Net Income

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Ebitda

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Ebit

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Net Income From Continuing Operations

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Income Before Tax

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Depreciation And Amortization

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Interest Income

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Net Interest Income

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Operating Expenses

1Y 2Y 5Y Max
9 days ago

MapLight Therapeutics, Inc. (MPLT) - Research And Development

1Y 2Y 5Y Max
9 days ago